Key result
Silencing Nox2 and Nox4 in c-kit+ cardiac precursor cells increases CPC markers and blunts differentiation.
Nox2 and Nox4 regulate the differentiation of c-kit+ cardiac precursor cells, suggesting they could be targets for cell-based cardiac therapies.
Nox2/Nox4 upregulation drives c-kit+ CPC differentiation; leaves open whether redox modulation enhances cardiac regeneration.
Redox status has emerged as critical in modulating stemness and lineage commitment in several precursor cell types. However, a role for redox genes, specifically NADPH oxidases (Nox), in cardiac precursor cells (CPCs) has not been established. We tested whether CPCs marked by type III receptor tyrosine kinase c-kit (c-kit(+)) exhibit a unique NADPH oxidase signature that confers precursor status and whether alterations in this profile are functionally linked to changes in lineage specification. Dihydroethidium (DHE) microfluorography indicated reduced basal reactive oxygen species (ROS) formation within early postnatal c-kit(+) CPCs. Real-time quantitative PCR revealed downregulation of ROS generator Nox2 and its subunit p67(phox) in c-kit(+) CPCs under basal conditions but upregulation of Nox2 and Nox4 over the course of differentiation. Adenoviral silencing of Nox2 and Nox4 increased expression of CPC markers c-kit and Flk-1 and blunted smooth and cardiac muscle differentiation, respectively, while overexpression of Nox2 and Nox4 significantly reduced c-kit expression. These changes were accompanied by altered expression of transcription factors regulating cardiac lineage commitment, Gata6 and Gata4, and cytokine transforming growth factor (TGF)-β1. Similar to other precursor cell types, RT(2)Profiler PCR Arrays revealed that c-kit(+) CPCs also exhibit enhanced antioxidant capacity at the mRNA level. In conclusion, we report that c-kit(+) CPCs demonstrate reduced Nox2 expression and ROS levels and that increases in Nox2 and Nox4 influence their differentiation into mature cells. We speculate that ROS generators Nox2 and Nox4, along with the antioxidant genes identified by PCR Arrays, may be novel targets in CPCs that could prove useful in cell-based therapy of the heart.
No takes yet. Share an insight, caveat, or question.
Nadworny et al. (2013) studied this question. Adenoviral silencing or overexpression of Nox2 and Nox4 vs. Basal conditions was evaluated on Expression of CPC markers and differentiation. Silencing Nox2 and Nox4 in c-kit+ cardiac precursor cells increased CPC marker expression and blunted differentiation, while overexpression reduced c-kit expression.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: